Flputnam Investment Management Co. Trims Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Flputnam Investment Management Co. reduced its holdings in UnitedHealth Group by 29.0%, owning 48,715 shares worth $25.5 million after selling 19,888 shares.
• UnitedHealth Group reported EPS of $4.08 for the last quarter, missing estimates by $0.37, with revenue of $111.62 billion, slightly below expectations.
• The company announced a quarterly dividend of $2.21 per share, translating to an annualized dividend yield of 2.9%.

Flputnam Investment Management Co. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 29.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,715 shares of the healthcare conglomerate's stock after selling 19,888 shares during the quarter. Flputnam Investment Management Co.'s holdings in UnitedHealth Group were worth $25,515,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC increased its holdings in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Schonfeld Strategic Advisors LLC increased its holdings in shares of UnitedHealth Group by 814.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 9,946 shares of the healthcare conglomerate's stock valued at $5,031,000 after purchasing an additional 11,338 shares during the period. Gallagher Fiduciary Advisors LLC increased its holdings in shares of UnitedHealth Group by 22.2% in the 4th quarter. Gallagher Fiduciary Advisors LLC now owns 876 shares of the healthcare conglomerate's stock valued at $443,000 after purchasing an additional 159 shares during the period. Finally, Alaethes Wealth LLC boosted its position in shares of UnitedHealth Group by 0.7% in the fourth quarter. Alaethes Wealth LLC now owns 4,647 shares of the healthcare conglomerate's stock valued at $2,351,000 after acquiring an additional 33 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $309.77 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $280.55 billion, a PE ratio of 13.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.43. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock's 50-day simple moving average is $288.16 and its 200 day simple moving average is $380.68.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

UNH has been the subject of several research reports. KeyCorp reduced their target price on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research report on Monday, May 19th. Bank of America boosted their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday, August 18th. Finally, Morgan Stanley lowered their price objective on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 20th. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $353.00.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.